Applied Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Funtleyder Leslie D. unloaded Company’s shares for reported $78880.0 on Aug 22 ’24. In the deal valued at $5.83 per share,13,530 shares were sold. As a result of this transaction, Funtleyder Leslie D. now holds 277,911 shares worth roughly $0.26 million.
Then, Perfetti Riccardo sold 22,681 shares, generating $132,230 in total proceeds. Upon selling the shares at $5.83, the Chief Medical Officer now owns 986,853 shares.
Before that, Shendelman Shoshana sold 357,423 shares. Applied Therapeutics Inc shares valued at $2,208,874 were divested by the President and CEO at a price of $6.18 per share. As a result of the transaction, Shendelman Shoshana now holds 4,810,430 shares, worth roughly $4.52 million.
William Blair downgraded its Applied Therapeutics Inc [APLT] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who decreased its forecast for the stock in early December from “a Buy” to “a Neutral”. RBC Capital Mkts also remained covering APLT and has decreased its forecast on November 29, 2024 with a “Sector perform” recommendation from previously “an Outperform” rating. William Blair started covering the stock on July 31, 2024. It rated APLT as “an Outperform”.
Price Performance Review of APLT
On Friday, Applied Therapeutics Inc [NASDAQ:APLT] saw its stock jump 5.07% to $0.94. Over the last five days, the stock has gained 6.44%. Applied Therapeutics Inc shares have risen nearly 10.22% since the year began. Nevertheless, the stocks have fallen -73.71% over the past one year. While a 52-week high of $10.62 was reached on 01/02/25, a 52-week low of $0.77 was recorded on 01/02/25. SMA at 50 days reached $5.3533, while 200 days put it at $5.6292.
Levels Of Support And Resistance For APLT Stock
The 24-hour chart illustrates a support level at 0.9020, which if violated will result in even more drops to 0.8604. On the upside, there is a resistance level at 0.9734. A further resistance level may holdings at 1.0032. The Relative Strength Index (RSI) on the 14-day chart is 20.82, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0543, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.95%. Stochastics %K at 26.02% indicates the stock is a holding.
How much short interest is there in Applied Therapeutics Inc?
A steep rise in short interest was recorded in Applied Therapeutics Inc stocks on 2024-12-13, growing by 4.59 million shares to a total of 18.15 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 13.56 million shares. There was a rise of 25.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 26, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $12 price target.
